Physician profile
Mark Nootens
NPI 1568491975
$6,553.06
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,585 · 2020: $902 · 2021: $2,017 · 2022: $885 · 2023: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,207.22 | 2019-2022 | |
| Medtronic Vascular, INC. | $900.98 | 2019-2020 | |
| Ekos Corporation | $720.27 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $497.90 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $406.12 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $401.33 | 2019-2022 | |
| Amgen INC. | $313.30 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $256.23 | 2021-2022 | |
| Esperion Therapeutics, INC. | $253.72 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $253.43 | 2019-2023 | |
| Medtronic, INC. | $241.90 | 2021-2023 | Azure Xt Dr Mri Surescan |
| Amarin Pharma, INC. | $223.42 | 2019-2022 | |
| Chiesi USA, INC. | $175.52 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $174.50 | 2019-2022 | |
| Boston Scientific Corporation | $114.30 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.79 | 2020-2022 | |
| Shockwave Medical, INC | $108.86 | 2021 | |
| Pfizer INC. | $59.48 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $47.50 | 2019-2021 | |
| Cardiovascular Systems INC. | $21.75 | 2019-2021 | |
| Lundbeck LLC | $16.77 | 2019 | |
| Abiomed | $14.27 | 2021 | |
| Medicomp INC | $12.48 | 2020 | |
| Vifor Pharma, INC. | $10.97 | 2019 | |
| Z-Medica, LLC | $8.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Nootens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.